Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years

Fanny Er Vuik, Stella Av Nieuwenburg, Marc Bardou, Iris Lansdorp-Vogelaar, Mário Dinis-Ribeiro, Maria J Bento, Vesna Zadnik, María Pellisé, Laura Esteban, Michal F Kaminski, Stepan Suchanek, Ondřej Ngo, Ondřej Májek, Marcis Leja, Ernst J Kuipers, Manon Cw Spaander, Fanny Er Vuik, Stella Av Nieuwenburg, Marc Bardou, Iris Lansdorp-Vogelaar, Mário Dinis-Ribeiro, Maria J Bento, Vesna Zadnik, María Pellisé, Laura Esteban, Michal F Kaminski, Stepan Suchanek, Ondřej Ngo, Ondřej Májek, Marcis Leja, Ernst J Kuipers, Manon Cw Spaander

Abstract

Objective: The incidence of colorectal cancer (CRC) declines among subjects aged 50 years and above. An opposite trend appears among younger adults. In Europe, data on CRC incidence among younger adults are lacking. We therefore aimed to analyse European trends in CRC incidence and mortality in subjects younger than 50 years.

Design: Data on age-related CRC incidence and mortality between 1990 and 2016 were retrieved from national and regional cancer registries. Trends were analysed by Joinpoint regression and expressed as annual percent change.

Results: We retrieved data on 143.7 million people aged 20-49 years from 20 European countries. Of them, 187 918 (0.13%) were diagnosed with CRC. On average, CRC incidence increased with 7.9% per year among subjects aged 20-29 years from 2004 to 2016. The increase in the age group of 30-39 years was 4.9% per year from 2005 to 2016, the increase in the age group of 40-49 years was 1.6% per year from 2004 to 2016. This increase started earliest in subjects aged 20-29 years, and 10-20 years later in those aged 30-39 and 40-49 years. This is consistent with an age-cohort phenomenon. Although in most European countries the CRC incidence had risen, some heterogeneity was found between countries. CRC mortality did not significantly change among the youngest adults, but decreased with 1.1%per year between 1990 and 2016 and 2.4% per year between 1990 and 2009 among those aged 30-39 years and 40-49 years, respectively.

Conclusion: CRC incidence rises among young adults in Europe. The cause for this trend needs to be elucidated. Clinicians should be aware of this trend. If the trend continues, screening guidelines may need to be reconsidered.

Keywords: colorectal cancer; epidemiology; screening.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Figures

Figure 1
Figure 1
Annual percent change (APC) in colorectal cancer (CRC) incidence from the European countries included in the analysis in adults aged 20–39 years, 1990–2016. Light green to dark green: significant increase in CRC incidence rate; blue: significant decrease in CRC incidence rate; grey: no significant trend.
Figure 2
Figure 2
Annual percent change (APC) in age-specific colorectal cancer (CRC), colon cancer and rectal cancer incidence rates in Europe, 1990–2016. *Indicates that APC is statistically significant different from zero.
Figure 3
Figure 3
Annual percent change (APC) in age-specific colorectal cancer (CRC), colon cancer and rectal cancer incidence rates in nine European countries, 1991–2014. Analyses on trend in incidence of CRC was based on nine countries: Slovenia, Norway, Denmark, Sweden, Finland, the Netherlands, Czech Republic, Switzerland and Greenland. Analyses on trend of incidence of colon cancer and rectum cancer was based on eight countries: Slovenia, Norway, Denmark, Sweden, Finland, the Netherlands, Czech Republic and Greenland. *Indicates that APC is statistically significant different from zero.
Figure 4
Figure 4
Annual percent change (APC) in age-specific colorectal cancer (CRC), colon cancer and rectal cancer mortality rates in Europe, 1990–2016. *Indicates that APC is statistically significant different from zero.

References

    1. Arnold M, Sierra MS, Laversanne M, et al. . Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017;66:683–91. 10.1136/gutjnl-2015-310912
    1. Doubeni CA, Corley DA, Quinn VP, et al. . Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut 2018;67:291–8. 10.1136/gutjnl-2016-312712
    1. Rosato V, Bosetti C, Levi F, et al. . Risk factors for young-onset colorectal cancer. Cancer Causes Control 2013;24:335–41. 10.1007/s10552-012-0119-3
    1. Siegel RL, Fedewa SA, Anderson WF, et al. . Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst 2017:109.
    1. Fitzmaurice C, Dicker D, Pain A, et al. . The Global Burden of Cancer 2013. JAMA Oncol 2015;1:505–27. 10.1001/jamaoncol.2015.0735
    1. Connell LC, Mota JM, Braghiroli MI, et al. . The rising incidence of younger patients with colorectal cancer: Questions about screening, biology, and treatment. Curr Treat Options Oncol 2017;18:23 10.1007/s11864-017-0463-3
    1. Peterse EFP, Meester RGS, Siegel RL, et al. . The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis i to inform the american cancer society colorectal cancer screening guideline. Cancer 2018;124:2964–73. 10.1002/cncr.31543
    1. Wolf AMD, Fontham ETH, Church TR, et al. . Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018;68:250–81. 10.3322/caac.21457
    1. Troeung L, Sodhi-Berry N, Martini A, et al. . Increasing incidence of colorectal cancer in adolescents and young adults aged 15-39 years in western australia 1982-2007: Examination of colonoscopy history. Front Public Health 2017;5 10.3389/fpubh.2017.00179
    1. Deng Y. Rectal Cancer in Asian vs. Western Countries: Why the Variation in Incidence? Curr Treat Options Oncol 2017;18:64 10.1007/s11864-017-0500-2
    1. Patel P, De P. Trends in colorectal cancer incidence and related lifestyle risk factors in 15-49-year-olds in Canada, 1969-2010. Cancer Epidemiol 2016;42:90–100. 10.1016/j.canep.2016.03.009
    1. Karahalios A, English DR, Simpson JA. Weight change and risk of colorectal cancer: a systematic review and meta-analysis. Am J Epidemiol 2015;181:832–45. 10.1093/aje/kwu357
    1. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011;29:415–45. 10.1146/annurev-immunol-031210-101322
    1. Wolin KY, Yan Y, Colditz GA, et al. . Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer 2009;100:611–6. 10.1038/sj.bjc.6604917
    1. Yuhara H, Steinmaus C, Cohen SE, et al. . Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 2011;106:1911–21. 10.1038/ajg.2011.301
    1. Fedirko V, Tramacere I, Bagnardi V, et al. . Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol 2011;22:1958–72. 10.1093/annonc/mdq653
    1. Botteri E, Iodice S, Bagnardi V, et al. . Smoking and colorectal cancer: a meta-analysis. JAMA 2008;300:2765–78. 10.1001/jama.2008.839
    1. Wei EK, Giovannucci E, Wu K, et al. . Comparison of risk factors for colon and rectal cancer. Int J Cancer 2004;108:433–42. 10.1002/ijc.11540
    1. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007;86:556–65. 10.1093/ajcn/86.3.556
    1. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164–79. 10.1007/BF00052777

Source: PubMed

3
Abonnieren